Dave Muoio

By Dave Muoio 01:33 pmFebruary 27, 2020
K Health, a free symptom checking app with optional paid telehealth features, announced this morning a $48 million Series C round led by 14W and Mangrove Capital. Anthem, Lerer Hippeau, Primary Ventures and other unnamed backers also contributed. WHAT THEY DO Using a dataset comprised of physician notes, lab results, treatments, prescriptions, prior visits and other anonymized interactions, K...
By Dave Muoio 04:29 pmFebruary 26, 2020
Tempo (formerly Pivot), a startup that’s building a consumer workout device that tracks movements via sensor, has opened up sales for its first product, which it will begin shipping in the summer. Called the Tempo Studio, the product takes the form of an in-home cabinet housing a 42-inch screen and a 3D vision camera that scans the user 30 times per second. Along with dumbbells, free weights, a...
By Dave Muoio 03:22 pmFebruary 26, 2020
Type 2 diabetes patients who received a continuous glucose monitoring (CGM) system as part of a virtual diabetes clinic program improved their HbA1c and near-uniformly said they were comfortable self-inserting a sensor with guidance from a remote coach, according to study data presented by Onduo at an academic conference last weekend. Further, while more than half of the study’s nearly 600...
By Dave Muoio 11:40 amFebruary 25, 2020
Apple and Johnson & Johnson announced this morning the launch of their new digital health study exploring the impact of Apple’s devices and a study-specific engagement program on cardiovascular outcomes among the Medicare population. First announced in early 2019, the Heartline Study — which also names Evidation Health as a collaborator — is now enrolling seniors aged 65 years or older who...
By Dave Muoio 07:50 pmFebruary 24, 2020
A full transcript of STARS-ADHD — the pivotal trial of Akili Interactive’s video game-like pediatric attention deficit treatment — has been published in The Lancet Digital Health journal, providing onlookers a clear view of data fueling the digital therapeutic company’s pending FDA submission. The writeup echoes topline findings first unveiled by the company in December 2017: compared to a...
By Dave Muoio 11:29 amFebruary 24, 2020
Healthcare benefits assistance platform HealthJoy has brought in a $30 million Series C funding round, according to a TechCrunch interview being promoted by the startup. Health Velocity Capital led the round, which also included returning backers US Venture Partners, Chicago Ventures and Epic Ventures, among other individual investors. WHAT THEY DO Founded in 2014, HealthJoy expanded its business...
By Dave Muoio 03:09 pmFebruary 21, 2020
Health research studies conducted using health research apps are capable of recruiting a large number of participants, but these efforts often see early dropouts and do not enrolls samples representative of the larger population, according to a study published this week in NPJ Digital Medicine. The investigation, headed by the science research-focused nonprofit Sage Bionetworks, reviewed user...
By Dave Muoio 03:50 pmFebruary 17, 2020
Digital diabetes management company Glooko has announced the appointments of a new CCO and COO. The first role went to Zach Henderson, formerly of LexisNexis Health Care and Elsevier, he will be in charge of key strategic partners and revenue generation for Glooko. “As the leader in diabetes data management, Glooko is integrated with more diabetes and health devices than any other platform in the...
By Dave Muoio 03:28 pmFebruary 17, 2020
Healthcare data company Innovaccer announced last week $70 million in new Series C funding raised from Steadview Capital, Tiger Global, Dragoneer, Westbridge, Mubadala and Microsoft’s M12. WHAT THEY DO By using artificial intelligence and data analytics, Innovaccer’s products handle a slew of processes for healthcare organizations. Among offerings are InCare, which automatically unifies...
By Dave Muoio 04:26 pmFebruary 14, 2020
A sample of low-income patients engaged with Omada Health’s digital diabetes prevention program (DPP), achieved weight loss but no major difference in HbA1c levels after a year of use, according to study data recently highlighted by the company. The results — published late last year in the CDC’s Preventing Chronic Disease journal and first previewed at a 2018 public health conference — suggest...